6.42
price up icon3.38%   0.21
after-market アフターアワーズ: 6.54 0.12 +1.87%
loading
前日終値:
$6.21
開ける:
$6.25
24時間の取引高:
2.12M
Relative Volume:
1.00
時価総額:
$826.22M
収益:
$628.25M
当期純損益:
$-78.55M
株価収益率:
-10.35
EPS:
-0.62
ネットキャッシュフロー:
$-29.73M
1週間 パフォーマンス:
-6.96%
1か月 パフォーマンス:
-8.29%
6か月 パフォーマンス:
-55.72%
1年 パフォーマンス:
-56.62%
1日の値動き範囲:
Value
$6.23
$6.56
1週間の範囲:
Value
$6.20
$7.065
52週間の値動き範囲:
Value
$6.08
$19.11

Neogenomics Inc Stock (NEO) Company Profile

Name
名前
Neogenomics Inc
Name
セクター
Healthcare (1161)
Name
電話
(239) 768-0600
Name
住所
9490 NEOGENOMICS WAY, FORT MYERS, FL
Name
職員
2,200
Name
Twitter
@NeoGenomics
Name
次回の収益日
2025-02-18
Name
最新のSEC提出書
Name
NEO's Discussions on Twitter

NEO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
NEO
Neogenomics Inc
6.42 887.99M 628.25M -78.55M -29.73M -0.62
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
427.62 157.79B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
189.91 138.02B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
532.00 42.36B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
116.19 32.08B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
187.38 27.28B 15.50B 1.33B 2.16B 7.34

Neogenomics Inc Stock (NEO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-15 開始されました Guggenheim Neutral
2025-04-30 ダウングレード Leerink Partners Outperform → Market Perform
2025-01-13 ダウングレード The Benchmark Company Buy → Hold
2024-12-10 開始されました Jefferies Buy
2024-05-01 再開されました Craig Hallum Buy
2023-12-29 繰り返されました BTIG Research Buy
2023-08-21 アップグレード Stephens Equal-Weight → Overweight
2023-05-16 ダウングレード Raymond James Outperform → Mkt Perform
2023-05-09 アップグレード BTIG Research Neutral → Buy
2023-02-24 アップグレード The Benchmark Company Hold → Buy
2023-02-01 アップグレード Needham Hold → Buy
2022-08-26 ダウングレード The Benchmark Company Buy → Hold
2022-08-22 ダウングレード Needham Buy → Hold
2022-06-03 開始されました Piper Sandler Overweight
2022-03-29 ダウングレード BofA Securities Buy → Neutral
2022-03-29 ダウングレード Stephens Overweight → Equal-Weight
2022-01-18 再開されました Stephens Overweight
2021-12-16 開始されました Cowen Outperform
2021-11-05 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-10-14 アップグレード Raymond James Mkt Perform → Outperform
2021-06-03 開始されました Goldman Buy
2021-02-25 再開されました Needham Buy
2021-02-25 ダウングレード Raymond James Outperform → Mkt Perform
2021-01-28 開始されました Truist Buy
2020-12-11 再開されました BTIG Research Buy
2020-10-28 繰り返されました Needham Buy
2020-09-09 開始されました Morgan Stanley Overweight
2020-08-28 開始されました Guggenheim Buy
2020-07-29 繰り返されました Needham Buy
2020-06-25 開始されました BofA/Merrill Buy
2020-04-21 再開されました Stephens Overweight
2020-03-02 再開されました Craig Hallum Buy
2020-02-28 アップグレード First Analysis Sec Outperform → Strong Buy
2020-01-23 ダウングレード First Analysis Sec Strong Buy → Outperform
2019-10-30 繰り返されました Needham Buy
2019-05-01 繰り返されました Needham Buy
2019-03-29 繰り返されました Needham Buy
2019-01-03 開始されました Needham Buy
2018-10-24 アップグレード First Analysis Sec Outperform → Strong Buy
2018-08-21 開始されました Leerink Partners Outperform
2018-05-02 ダウングレード First Analysis Sec Overweight → Equal-Weight
2017-09-11 ダウングレード BTIG Research Buy → Neutral
2017-08-24 開始されました Gabelli & Co Buy
2016-12-15 開始されました Cantor Fitzgerald Overweight
すべてを表示

Neogenomics Inc (NEO) 最新ニュース

pulisher
01:07 AM

Is NeoGenomics Inc. a good long term investmentExplosive earnings growth - jammulinksnews.com

01:07 AM
pulisher
12:37 PM

What drives NeoGenomics Inc. stock priceRapid-fire capital growth - jammulinksnews.com

12:37 PM
pulisher
09:43 AM

NeoGenomics (NEO) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

09:43 AM
pulisher
07:44 AM

NeoGenomics Inc. Stock Analysis and ForecastDynamic investment opportunities - jammulinksnews.com

07:44 AM
pulisher
Jul 20, 2025

What analysts say about NeoGenomics Inc. stockUnmatched profit potential - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Personalized ctDNA monitoring in metastatic HR+/HER2− breast cancer patients during endocrine and CDK4/6 inhibitor therapy - Nature

Jul 19, 2025
pulisher
Jul 18, 2025

Neogenomics Shares Plunge 7.14% Amid Earnings Woes - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know - Yahoo Finance

Jul 18, 2025
pulisher
Jul 17, 2025

Pathological Examination Market Gaining Momentum in Cancer - openPR.com

Jul 17, 2025
pulisher
Jul 16, 2025

NeoGenomics (NASDAQ:NEO investor five-year losses grow to 81% as the stock sheds US$71m this past week - simplywall.st

Jul 16, 2025
pulisher
Jul 15, 2025

Why NeoGenomics Inc. stock attracts strong analyst attention200 Percent Profit Outlook - beatles.ru

Jul 15, 2025
pulisher
Jul 14, 2025

Q1 Earnings Highlights: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Testing & Diagnostics Services Stocks - Yahoo Finance

Jul 14, 2025
pulisher
Jul 11, 2025

NEO Stock Price and Chart — NASDAQ:NEO - TradingView

Jul 11, 2025
pulisher
Jul 11, 2025

NeoGenomics, RadNet, Pediatrix Medical Group, Penumbra, and Neogen Shares Plummet, What You Need To Know - Yahoo Finance

Jul 11, 2025
pulisher
Jul 11, 2025

NeoGenomics Announces Grand Opening of New Pharma Services Laboratory in Singapore - ACCESS Newswire

Jul 11, 2025
pulisher
Jul 10, 2025

Press Release: NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025 - 富途牛牛

Jul 10, 2025
pulisher
Jul 05, 2025

NeoGenomics (NEO): A Contrarian Play on Turnaround and Undervaluation - AInvest

Jul 05, 2025
pulisher
Jul 05, 2025

The past five years for NeoGenomics (NASDAQ:NEO) investors has not been profitable - Yahoo Finance

Jul 05, 2025
pulisher
Jul 03, 2025

NeoGenomics Announces Chief Executive Officer Appointment - ACCESS Newswire

Jul 03, 2025
pulisher
Jul 02, 2025

Here’s Why NeoGenomics (NEO) Sold Off in Q1 - Insider Monkey

Jul 02, 2025
pulisher
Jul 02, 2025

NeoGenomics To Participate In Fireside Chat At Stephens 21st Annual Investment Conference - ACCESS Newswire

Jul 02, 2025
pulisher
Jul 01, 2025

NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025 - Bluefield Daily Telegraph

Jul 01, 2025
pulisher
Jun 30, 2025

NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care - The Joplin Globe

Jun 30, 2025
pulisher
Jun 24, 2025

5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call - Yahoo Finance

Jun 24, 2025
pulisher
Jun 18, 2025

NeoGenomics' Market Cap Drops To US$954m Leaving Insiders With Losses - simplywall.st

Jun 18, 2025
pulisher
Jun 18, 2025

NeoGenomics Requests to Dismiss Class Action Filed by Investors - TradingView

Jun 18, 2025
pulisher
Jun 18, 2025

NeoGenomics drops as sequential revenue decline leads to Q1 miss - MSN

Jun 18, 2025
pulisher
Jun 06, 2025

NeoGenomics Schedules its First Quarter 2021 Earnings Release for May 5, 2021 - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 03, 2025

Investor Calendar Invites You to the NeoGenomics Fourth Quarter and Fiscal Year 2015 Earnings Conference Call and Webcast Live on Tuesday March 1, 2016 - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 03, 2025

NeoGenomics at William Blair Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

NeoGenomics at William Blair Conference: Strategic Growth and Innovation - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

Where are the Opportunities in (NEO) - news.stocktradersdaily.com

Jun 03, 2025
pulisher
Jun 02, 2025

Cancer Tumor Profiling Market Rises with Demand - openPR.com

Jun 02, 2025
pulisher
Jun 02, 2025

Liquid Biopsy Market for Cancer Detection, cfDNA & CTC Analysis | - openPR.com

Jun 02, 2025
pulisher
May 29, 2025

Fort Myers-based NeoGenomics to unveil new cancer diagnostics at ASCO 2025 - Gulfshore Business

May 29, 2025
pulisher
May 29, 2025

NeoGenomics unveils new oncology diagnostics at ASCO 2025 By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 28, 2025

Neogenomics director Kelly buys $38,000 in common stock - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

Neogenomics director Kelly buys $38,000 in common stock By Investing.com - Investing.com Nigeria

May 28, 2025
pulisher
May 28, 2025

NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025 - BioSpace

May 28, 2025
pulisher
May 28, 2025

NeoGenomics unveils new oncology diagnostics at ASCO 2025 - Investing.com

May 28, 2025

Neogenomics Inc (NEO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research WAT
$287.46
price up icon 2.06%
$139.92
price down icon 0.50%
diagnostics_research DGX
$178.24
price up icon 7.08%
diagnostics_research LH
$252.07
price up icon 3.72%
diagnostics_research MTD
$1,218.96
price up icon 4.50%
diagnostics_research IQV
$187.38
price up icon 17.88%
大文字化:     |  ボリューム (24 時間):